Abstract
The objective was to assess histopathological changes and the expression of proliferating cell nuclear antigen (PCNA), Bcl-2, suppressor of cytokine signaling (SOCS) 1 and 3, Vimentin, TWIST1, and Cdh 1 and 2 in early stages of experimental oral carcinogenesis process using a shorter period of exposure to 4-nitroquinoline oxide (4-NQO) model. In this study, 20 rats were divided into control group (n = 10), sacrificed on the first day of the experiment, and experimental group (n = 10) treated with 50 ppm of 4-NQO solution dissolved in drinking water for 8 and 12 weeks. The histological sections were stained with H&E or subjected to immunohistochemistry for detecting PCNA, Bcl-2, SOCS 1 and 3, and STAT 3. Some specimens were used for verification of Vimentin expression, Cdh 1, Cdh 2, and TWIST1 by RT-qPCR. At both 8 and 12 weeks, morphological changes occurred mainly in the posterior portion of the tongue and were limited to the epithelial tissue, including moderate to severe dysplasia at 8 weeks, and severe dysplasia with exacerbation of atypical cells at 12 weeks. Expression of SOCS 1 and 3 increased from 8 to 12 weeks (P < 0.05), whereas STAT 3 expression was reduced mainly at 12 weeks (P < 0.05) in comparison with the control...Continue Reading
References
Feb 1, 1995·International Journal of Oral and Maxillofacial Surgery·J M NautaA Vermey
Feb 12, 1998·Oral Oncology·I van der WaalL E Smeele
Jun 17, 1999·Journal of Dental Research·A Nishimura
Jul 31, 2003·British Journal of Cancer·M RaccurtM J Waters
Jul 12, 2005·Oncogene·Anette WeberAndrea Tannapfel
Nov 4, 2005·Oral Oncology·B MognettiG N Berta
Nov 17, 2005·Proceedings of the National Academy of Sciences of the United States of America·Akihiro KimuraTadamitsu Kishimoto
Nov 29, 2005·International Journal of Experimental Pathology·Daniel A RibeiroMariângela E A Marques
Feb 2, 2006·Oral Oncology·Deepak Kanojia, Milind M Vaidya
Mar 21, 2006·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Antonia SiogaKostantinos Antoniades
Jan 30, 2007·Oral Oncology·Marilena VeredDan Dayan
Mar 23, 2007·Gut·I TischoffA Tannapfel
Sep 23, 2008·Oral Oncology·Saman Warnakulasuriya
Jan 30, 2009·Digestion·Hajime Isomoto
Jul 18, 2009·Immunology Letters·Li SuJun Zhou
Oct 24, 2009·Nature Reviews. Cancer·Hua YuRichard Jove
Nov 3, 2009·Trends in Immunology·Douglas C Palmer, Nicholas P Restifo
Apr 8, 2010·International Journal of Oncology·John C CooperChao-Lan Yu
Jan 31, 2012·Journal of Molecular Histology·Juliana G CarvalhoDaniel A Ribeiro
Oct 3, 2012·PloS One·Carlos RossaKeith L Kirkwood
Jan 2, 2013·Frontiers in Bioscience (Scholar Edition)·Zoran Culig
Feb 2, 2013·Japanese Journal of Clinical Oncology·Zhenzhong FengJiawei Chen
Feb 26, 2013·British Journal of Haematology·Ommoleila MolaviRaymond Lai
Mar 23, 2013·PloS One·Xiaoju ZhangXitao Ma
Apr 23, 2013·Biochimica Et Biophysica Acta·Zakir Khan, Prakash S Bisen
Aug 16, 2013·Dental Research Journal·Juliana NogutiDaniel Araki Ribeiro
Sep 27, 2013·JAK-STAT·Kyoko Inagaki-OharaAkihiko Yoshimura
Oct 2, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yuxin WangGeorge R Stark
Nov 23, 2013·Clinical Oral Investigations·Jianjiang ZhaoJun Chen
Jan 15, 2014·Asian Pacific Journal of Tropical Medicine·Ge-Liang LiuYun-Zhao Lin
Jan 25, 2014·Journal of Gynecologic Oncology·Wei-Ning YangYin-Cheng Teng
Apr 8, 2014·Cellular and Molecular Life Sciences : CMLS·Julhash U KaziLars Rönnstrand
Jun 3, 2014·Journal of Experimental & Clinical Cancer Research : CR·Ryoichi FujiiKaoru Ogawa
Oct 21, 2014·Journal of Oral and Maxillofacial Pathology : JOMFP·Monica MehendirattaAashima Mohindra
Mar 31, 2015·Oral Oncology·Shrikant Balasaheb Mali
Jul 28, 2015·PloS One·Yink Heay KongSok Ching Cheong
Aug 13, 2015·Journal of Clinical and Diagnostic Research : JCDR·Chandrashekar PoosarlaMurali Sundar